Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease-Reference-Cited by-同舟云学术

Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease

Published:2016-02-29 Issue:2 Volume:135 Page:252-256
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Han S. -H.¹,Lee J. -H.²,Kim S. Y.³,Park K. W.⁴,Chen C.⁵,Tripathi M.⁶,Dash A.⁷,Kubota N.⁸

Affiliation:

1. Department of Neurology; Konkuk University Hospital; Seoul South Korea

2. Department of Neurology; University of Ulsan College of Medicine; Asan Medical Center; Seoul South Korea

3. Department of Neurology; Clinical Neuroscience Center & Neurology; Seoul National University Bundang Hospita; Gyeonggi-do South Korea

4. Department of Neurology; Dong-A University College of Medicine; Dong-A University Hospital; Busan South Korea

5. Department of Pharmacology; National University of Singapore and Memory Aging and Cognition Center; National University Health System; Singapore Singapore

6. Department of Neurology; Neuroscience Centre; AIIMS; New Delhi India

7. Regional Medical Advisor; Eisai Pharmaceuticals India Pvt. Ltd.; Mumbai India

8. Clinical Development Eisai Co. Ltd.; Tokyo Japan

Funder

Eisai Co., Ltd

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12571/fullpdf

Reference9 articles.

1. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex;Kuhl;Ann Neurol,2000

2. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease;Kaasinen;J Clin Psychopharmacol,2002

3. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: a 24-week, randomized, double-blind study;Farlow;Clin Ther,2010

4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals For Human Use http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023;Frontiers in Pharmacology;2024-07-17

2. Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System;CNS Drugs;2023-06-21

3. Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systematic review and meta-analysis;Expert Opinion on Drug Safety;2022-01-31

4. Anti-dementia Medications: Specific Agents;NeuroPsychopharmacotherapy;2022

5. Ameliorating Alzheimer’s-like pathology by Minocycline via inhibiting Cdk5/p25 signaling;Current Neuropharmacology;2021-12-02